BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26869407)

  • 1. Stroke and Drug Delivery--In Vitro Models of the Ischemic Blood-Brain Barrier.
    Tornabene E; Brodin B
    J Pharm Sci; 2016 Feb; 105(2):398-405. PubMed ID: 26869407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain endothelial cell specific integrins and ischemic stroke.
    Guell K; Bix GJ
    Expert Rev Neurother; 2014 Nov; 14(11):1287-92. PubMed ID: 25262658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.
    Chen YJ; Wallace BK; Yuen N; Jenkins DP; Wulff H; O'Donnell ME
    Stroke; 2015 Jan; 46(1):237-44. PubMed ID: 25477223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats.
    Bake S; Okoreeh AK; Alaniz RC; Sohrabji F
    Endocrinology; 2016 Jan; 157(1):61-9. PubMed ID: 26556536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery systems for the treatment of ischemic stroke.
    Rhim T; Lee DY; Lee M
    Pharm Res; 2013 Oct; 30(10):2429-44. PubMed ID: 23307348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
    Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
    J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New progress in the approaches for blood-brain barrier protection in acute ischemic stroke.
    Li Y; Zhong W; Jiang Z; Tang X
    Brain Res Bull; 2019 Jan; 144():46-57. PubMed ID: 30448453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier Na transporters in ischemic stroke.
    O'Donnell ME
    Adv Pharmacol; 2014; 71():113-46. PubMed ID: 25307215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurovascular unit transport responses to ischemia and common coexisting conditions: smoking and diabetes.
    Sifat AE; Vaidya B; Villalba H; Albekairi TH; Abbruscato TJ
    Am J Physiol Cell Physiol; 2019 Jan; 316(1):C2-C15. PubMed ID: 30207783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine pre-exposure reduces stroke-induced glucose transporter-1 activity at the blood-brain barrier in mice.
    Shah KK; Boreddy PR; Abbruscato TJ
    Fluids Barriers CNS; 2015 Apr; 12():10. PubMed ID: 25925411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Drug Delivery Systems for the Stroke Intervention and Recovery.
    Luo T; Wang J; Hao S; Guo T; Ren P; Cheng Z; Gao F; Gong Y; Wang B
    Curr Pharm Des; 2017; 23(15):2258-2267. PubMed ID: 27784243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hyperglycemia worsens ischemic stroke-induced brain damage via high mobility group box-1 in rats.
    Huang J; Liu B; Yang C; Chen H; Eunice D; Yuan Z
    Brain Res; 2013 Oct; 1535():148-55. PubMed ID: 24012767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of blood-brain barrier transporters in pathophysiology and pharmacotherapy of stroke.
    Shah K; Abbruscato T
    Curr Pharm Des; 2014; 20(10):1510-22. PubMed ID: 23789950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery to the ischemic brain.
    Thompson BJ; Ronaldson PT
    Adv Pharmacol; 2014; 71():165-202. PubMed ID: 25307217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvaging brain ischemia by increasing neuroprotectant uptake via nanoagonist mediated blood brain barrier permeability enhancement.
    Zheng S; Bai YY; Liu Y; Gao X; Li Y; Changyi Y; Wang Y; Chang D; Ju S; Li C
    Biomaterials; 2015 Oct; 66():9-20. PubMed ID: 26188608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioneurins - Key regulators of blood-brain barrier integrity during hypoxic and ischemic brain injury.
    Kunze R; Marti HH
    Prog Neurobiol; 2019 Jul; 178():101611. PubMed ID: 30970273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.